Loan Loss Reserves / Non-Performing Loans (Quarterly)

Loan Loss Reserves / Non-Performing Loans: Allowance for bad loans as a portion of total loans made. Calculated as: Loan Loss Reserves / Non-Performing Loans

BioNTech SE Sponsored ADR (BNTX) Loan Loss Reserves / Non-Performing Loans data is not available.

Quarterly Annual

Figures for fiscal quarter ending 2026-03-31

Income Statement Financials
Revenue	$138.22M
Net Income	$-622.54M
Cost of Goods Sold	$83.57M
Gross Profit	$54.66M
Operating Expenses	$931.17M
Operating Income	$-792.95M
Non-Operating Income/Expense	$128.04M
Pre-Tax Income	$-664.90M
Normalized Pre-Tax Income	$-664.90M
Income after Taxes	$-622.54M
Income from Continuous Operations	$-622.54M
Consolidated Net Income/Loss	$-622.54M
Normalized Income after Taxes	$-622.54M
EBIT	$-792.95M
EBITDA	$-650.98M
Weighted-Average Shares Outstanding (Basic)	253.27M
Weighted-Average Shares Outstanding (Diluted)	253.27M
Earnings per Share (EPS) (Basic)	$-2.46
Earnings per Share (EPS) (Diluted)	$-2.46
Balance Sheet Financials
Current Assets	$18.18B
Property, Plant, and Equipment	$1.30B
Long-Term Assets	$6.49B
Total Assets	$24.67B
Current Liabilities	$2.07B
Long-Term Debt	$288.04M
Long-Term Liabilities	$715.47M
Total Liabilities	$2.78B
Common Equity	$21.88B
Tangible Shareholders Equity	$19.64B
Shareholders Equity	$21.88B
Common Shares Outstanding	252.88M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-492.74M
Cash Flow from Investing Activities	$3.10B
Cash Flow from Financial Activities	$30.90M
Beginning Cash	$8.98B
End Cash	$11.63B
Increase/Decrease in Cash	$2.65B
Stock-Based Compensation	$24.23M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	8.80
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.01
Debt to Equity Ratio	0.02
Gross Margin	39.54%
Operating Margin	-573.67%
EBIT Margin	-573.67%
EBITDA Margin	--
Pre-Tax Profit Margin	-481.03%
Profit Margin	-450.38%
Free Cash Flow	$-557.34M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.01
Inventory Turnover	0.69
Receiveable Turnover	0.20
Days Sales in Receivables	459.75
Return on Equity	-2.84%
Return on Tangible Equity	-3.17%
Return on Assets	-2.52%
Return on Investments	-2.81%
Book Value Per Share	$86.54
Free Cash Flow per Share	$-2.20
Operating Cash Flow per Share	$-1.95

Data from Zacks Investment Research, Inc.